Egypt, Pfizer discuss expanding healthcare collaboration
Egypt's Minister of Health and Population, Khaled Abdel Ghaffar, held talks with representatives from Pfizer on the…
Browsing Tag
Pfizer
S&P puts positive outlook on Ireland’s credit rating
S&P Global Ratings assigned a positive outlook to Ireland’s credit rating, emphasising the country's strong…
Pfizer sells $3.9b of stakes in Haleon
Haleon, British multinational consumer healthcare company, announced on Tuesday that its top shareholder, Pfizer,…
AstraZeneca forecasts profit rise
AstraZeneca announced on Thursday that it anticipates a rise in this year’s revenue and profit due to strong demand…
2023 Nobel prize awarded to scientists behind Covid vaccines
The 2023 Nobel Prize in Physiology or Medicine has been awarded to biochemist Katalin Karikó and immunologist Drew…
Pfizer, Flagship Pioneering to invest $100 mln in drug discovery
Pfizer and venture firm, Flagship Pioneering, are investing $100 million to develop 10 new potential drugs for…
Pfizer to deliver cancer therapy after Seagen acquisition
Pfizer CEO, Albert Bourla, said on Monday that the huge firm will be able to deliver Seagen’s cancer therapy at an…
Pfizer in talks to buy Seagen for more than $30bln
U.S. pharmaceutical giant Pfizer Inc. is in early talks to buy drug making company Seagen Inc. and it has cited…
Pfizer to invest $470m to develop research of coronavirus vaccine technology
Pfizer plans to spend $470 million to expand its vaccine research and development facilities in north-west of New…
Egypt to receive first shipment of Pfizer, J&J vaccine doses soon – minister
Egypt is set to receive its first shipment of the U.S. Pfizer and Johnson & Johnson (J&J) COVID-19 vaccines…
Pfizer, BioNTech apply for coronavirus vaccine approval in Europe
U.S. pharmaceutical giant Pfizer and its German partner BioNTech said they have applied to the European Medicines…
Pfizer to apply for emergency U.S. authorization within days for its COVID-19 vaccine
Final results from Pfizer Inc’s COVID-19 vaccine trial showed its shot had a 95 percent success rate and two months…
Egypt agrees with GAVI to secure 20 million doses of candidate coronavirus vaccines
Egypt announced on Wednesday an agreement with the GAVI vaccine alliance to provide the country with 20 million…
Egypt reserves doses of anticipated Pfizer and Oxford trial coronavirus vaccines –…
Egypt has reserved doses of a potential coronavirus vaccine developed by Pfizer Inc and BioNTech that would cover…
Egypt’s stock market indices jump on coronavirus vaccine hopes
Gains on global shares have propelled Egypt’s stock exchange’s (EGX) indexes ending higher on Tuesday, with the…
World Health Organisation chief hails Pfizer coronavirus vaccine as…
The World Health Organisation (WHO) chief Tedros Adhanom Ghebreyesus on Monday hailed Pfizer and BioNTech's…
Pfizer says COVID-19 vaccine is more than 90% effective in preventing infection
Pfizer said its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from…
Pfizer, BioNTech may get $2 billion from US for 100 million doses of potential coronavirus…
The US government will pay $1.95 billion for Pfizer and BioNTech when the companies manufacture potential…
Pfizer, BioNTech shares surge after US deal of $2 billion for 100 million doses of…
Shares of both Pfizer and BioNTech surged; Pfizer jumped as much as 6 percent, while BioNTech rose nearly 8 percent…
U.S., Pfizer Inc. and BioNTech COVID-19 vaccine deal sets a ceiling for doses sale
The U.S., Pfizer Inc. and BioNTech SE are setting a price ceiling of less than $20 a dose after signing a $2…
U.S. to pay Pfizer, BioNTech $2 billion for 100 million doses of coronavirus vaccine
United States will pay Pfizer and German biotech firm BioNTech $1.95 billion to produce and deliver 100 million…
Pfizer says to test a coronavirus vaccine in thousands of people in September
Pfizer is planning to test its experimental coronavirus vaccine in thousands of people next September if the…
Pfizer may outsource manufacturing some of its drugs to make way for coronavirus vaccine
Pfizer plans to outsource production of some of its drug portfolio to make way for a rapidly growing vaccine…
Pfizer, New York University working on coronavirus vaccine, could be ready by end of…
Researchers at Pfizer and New York University announced on Tuesday that they are working on a never-before-tried …
BioNTech, Pfizer testing potential coronavirus vaccine, could “supply…
German drugmaker BioNTech and U.S. pharmaceutical giant Pfizer have begun human trials of a potential coronavirus…
Germany approves first human trials of new coronavirus vaccine
Germany’s Federal Institute for Vaccines has approved on Wednesday the first human trials of a potential…
Pfizer raises U.S. prices for over 100 drugs on January 1
Pfizer Inc (PFE.N), which plans a $160-billion merger with Ireland-based Allergan Plc (AGN.N) to slash its U.S. tax…
Pfizer wins EU approval for $15 billion Hospira buy
U.S. drugmaker Pfizer (PFE.N) gained European Union antitrust approval on Tuesday for its proposed $15 billion…
China up, Europe down after Wall Street gains
China's stock benchmark rose Monday while ones in Japan and Europe fell as investors looked ahead to Apple results…
Pfizer Beats Sales and Profit Forecasts, Mum on Future Deals
Pfizer Inc (PFE.N) reported stronger-than-expected quarterly results, helped by growing sales of its cancer drugs…
Pfizer-Astrazeneca Impasse Has Wall Street Baffled By U.K. Rules
The U.K.’s updated Takeover Code was supposed to make acquisitions of British companies more transparent. Instead,…
Pfizer $117 Billion Astrazeneca Hunt Said Likely To Fail
Pfizer Inc. (PFE)’s 69.4 billion-pound ($117 billion) pursuit of British drugmaker AstraZeneca Plc (AZN) is likely…
Pfizer Boss Enters Lion’s Den of UK Politics to Sell Astrazeneca Deal
The boss of U.S. drugmaker Pfizer faces UK lawmakers on Tuesday with a promise and a threat - to protect British…
Pfizer says AstraZeneca Takeover Would Benefit Science
Pfizer (PFE.N) sought to allay fears that its proposed $106 billion takeover of AstraZeneca (AZN.L) would deal a…
Pfizer says AstraZeneca Takeover Would Benefit Science
Pfizer (PFE.N) sought to allay fears that its proposed $106 billion takeover of AstraZeneca (AZN.L) would deal a…
Wall Street Dips As Ukraine Concern Offsets Upbeat Jobs Data
U.S. stocks eased on Friday as concerns about more violence in Ukraine prompted profit-taking ahead of the weekend…
AstraZeneca Rejects Pfizer’s Raised Bid of $106 billion
U.S. drugmaker Pfizer Inc increased its offer for AstraZeneca Plc to 63 billion pounds ($106 billion) on Friday,…
Astrazeneca: Pfizer Made No Specific Merger Offer
AstraZeneca PLC said Monday it didn't receive a specific acquisition proposal from Pfizer Inc. PFE +0.13%, and…
Pfizer Steps up $100 Billion Bid for Astrazeneca
Pfizer Inc. confirmed Monday that it made a renewed approach to AstraZeneca PLC regarding a takeover valued at…
Nestle Wins Pfizer’s Battle
Swiss food group Nestle is to buy drug maker Pfizer's baby food business for $11.85 billion, beating out French…